AnaptysBio Inc.
ANAB | NASDAQ
$48.01
-$0.27 (-0.56%)
Nov 2, 2026, 10:41 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 183.88M | -52.88M | 49.61M | 15.11M | -38.63M | -39.33M | -21.78M | -32.85M | -46.66M | -43.94M | -42.21M | -37.31M | -39.85M | -44.26M | -26.41M | -33.5M | -32.55M | -36.26M | -32.54M | -6.67M | -429K | -18.16M |
Depreciation & Amortization | 358K | 610K | 606K | 610K | 601K | 606K | 601K | 596K | 595K | 605K | 604K | 592K | 587K | 593K | 606K | 585K | 571K | 573K | 385K | 669K | 785K | 125K |
Stock-Based Compensation | -5.9M | 14.22M | 8.51M | 9.16M | 9.24M | 9.17M | 8.18M | 8.19M | 7.54M | 10.13M | 8.11M | 7.81M | 8.43M | 8.86M | 6.69M | 6.27M | 6.66M | 7.74M | 3.98M | 4.36M | 3.69M | 3.32M |
Other Working Capital | -5.69M | 2.01M | 477K | -793K | -3.61M | 3.61M | -158K | -6.84M | 2.62M | -1.99M | 2.42M | -6.21M | -1.7M | -340K | 1.32M | 2.44M | -4.49M | -1.58M | 6.76M | -5.15M | -938K | 372.66M |
Other Non-Cash Items | 14.58M | 19.85M | 19.37M | 21.39M | 18.01M | 16.39M | 15.1M | 15.3M | 8.48M | 3.35M | 4.96M | 4.43M | 2.18M | 2.15M | 2.53M | 5.35M | 5.71M | 5.02M | 1.55M | 85K | 126K | 167K |
Deferred Income Tax | -183.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.15M | -2.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -35.86M | -7.71M | 19.9M | -73.62M | -29.46M | 2.46M | -68.78M | -1.32M | 8.72M | -7.4M | -2.66M | -9M | 3.25M | 8.09M | 5.91M | 3.55M | -4.53M | 1.91M | 1.32M | -5.46M | 5.42M | -8.65M |
Operating Cash Flow | -26.64M | -25.92M | 98M | -27.36M | -40.24M | -10.7M | -66.67M | -10.09M | -21.32M | -37.25M | -34.35M | -36.47M | -25.41M | -24.57M | -10.69M | -17.75M | -24.15M | -21.01M | -25.3M | -7.01M | 9.59M | -23.2M |
Capital Expenditures | 17K | -17K | -1K | -12K | -39K | -35K | -263K | -35K | -33K | -27K | -280K | -162K | -190K | -175K | -175K | -50K | -78K | -55K | -14K | -172K | -863K | -317K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.46M | -30.8M | n/a | n/a | -21.67M | 32.38M | 70.92M | n/a | n/a | n/a | n/a | 6.24M |
Purchase of Investments | -4.96M | n/a | n/a | -19.66M | -54.21M | -122.55M | -120.88M | -51.35M | -149.15M | -59M | -66.31M | -70.05M | -119.01M | -48.56M | -127.58M | -180.13M | -172.32M | -322.48M | -92.18M | -16.75M | -3.5M | -6.24M |
Sales Maturities Of Investments | 12.5M | 35M | 73.5M | 122.95M | 90.65M | 137.43M | 91.75M | 110M | 146.74M | 127.64M | 115.77M | 100.85M | 98.74M | 134.13M | 149.25M | 147.75M | 101.4M | 9.62M | 25.5M | 27.74M | 42.32M | 63.28M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 49.46M | 30.8M | n/a | n/a | 21.67M | -32.38M | -70.92M | n/a | n/a | 15K | n/a | -6.24M |
Investing Cash Flow | 7.56M | 34.98M | 73.5M | 103.28M | 36.4M | 14.85M | -29.4M | 58.62M | -2.44M | 68.62M | 49.18M | 30.64M | -20.46M | 85.4M | 21.5M | -32.43M | -71M | -312.91M | -66.69M | 10.84M | 37.96M | 56.73M |
Debt Repayment | -6.92M | -12.81M | -51.96M | -1.01M | -823K | n/a | n/a | -26.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -3.38M | -9.72M | -51.1M | -4.42M | -456K | n/a | n/a | n/a | n/a | n/a | -12.47M | -37.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -100M | n/a | n/a | n/a | n/a | -24.46M | 27.47M | -370K | 40.91M | -14.44M | -5.42M | -3.23M | -1.8M | -1.31M | -1.47M | 34.33M | -433K | -235K | 249.75M | n/a | n/a | n/a |
Financial Cash Flow | -95.57M | 1.21M | -43.13M | -10.39M | -50.5M | -28.59M | 27.57M | 71.23M | 41.89M | -13.63M | -5.16M | -3.07M | -13.49M | -37.57M | 1.95M | 37.03M | 432K | 4.61M | 251.34M | 241K | 554K | 167K |
Net Cash Flow | -114.64M | 10.27M | 128.36M | 65.54M | -54.34M | -24.44M | -68.5M | 119.76M | 18.13M | 17.73M | 9.67M | -8.91M | -59.36M | 23.25M | 12.76M | -13.15M | -94.71M | -329.32M | 159.34M | 4.07M | 48.11M | 33.69M |
Free Cash Flow | -26.62M | -25.94M | 98M | -27.37M | -40.28M | -10.74M | -66.94M | -10.13M | -21.36M | -37.28M | -34.63M | -36.64M | -25.6M | -24.74M | -10.86M | -17.8M | -24.23M | -21.07M | -25.32M | -7.18M | 8.73M | -23.52M |
Adj. Free Cash Flow | -20.73M | -40.15M | 89.49M | -36.53M | -49.52M | -19.91M | -75.12M | -18.31M | -28.9M | -47.41M | -42.74M | -44.44M | -34.03M | -33.6M | -17.55M | -24.07M | -30.88M | -28.81M | -29.29M | -11.54M | 5.04M | -26.84M |
Maintenance CapEx | -17K | -17K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -33.73K | n/a | -50K | -78K | -55K | -14K | n/a | n/a | -317K |
Growth CapEx | 34K | n/a | -1K | -12K | -39K | -35K | -263K | -35K | -33K | -27K | -280K | -162K | -190K | -141.27K | -175K | n/a | n/a | n/a | n/a | -172K | -863K | n/a |
Owner Earnings | -26.66M | -25.94M | 98M | -27.36M | -40.24M | -10.7M | -66.67M | -10.09M | -21.32M | -37.25M | -34.35M | -36.47M | -25.41M | -24.6M | -10.69M | -17.8M | -24.23M | -21.07M | -25.32M | -7.01M | 9.59M | -23.52M |
Add to Watchlist
Select watchlists to add or remove ANAB